Press Room

Washington D.C. – September 16, 2026 – New York State Sen.

The New York State Senate began its wrap up of the 2026 legislative session by advancing bipartisan legislation (Senate Bill 172b) that would improve New Yorkers’ access to paid medical leave through the state’s Temporary Disability Insurance (TDI) Program. Despite overwhelming support from the Assembly majority conference, the companion legislation (Assembly Bill 9571a) is not expected to be taken up before the Assembly adjourns. Advocates with the American Cancer Society Cancer Action Network (ACS CAN) are expressing their disappointment that the Assembly may allow the effort to fail for the third year in a row.

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.  

Earlier today, a coalition of patient advocates, legislative champions, public health leaders and concerned cancer survivors, led by the American Cancer Society Cancer Action Network (ACS CAN), came together to applaud the Senate and call on Governor Hochul and Assembly leadership to join the Senate in preserving Medicaid enrollees’ access to biomarker testing.

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.  

Following today’s health-Medicaid budget hearing, more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on lawmakers to preserve access to biomarker testing, a priority shared by over 100 organizations statewide. Advocates also expressed hope that the one‑house and final budgets will include meaningful investments in cancer prevention and early detection. 

As New York State’s 2026 legislative session begins and Governor Hochul prepares to deliver her State of the State address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on lawmakers to seize both immediate and long-term opportunities to ease the burden of cancer. Advocates are urging state leaders to prioritize affordability and ensure continued progress in the fight against this disease.

During Lung Cancer Awareness Month, cancer patients, survivors and volunteers with the American Cancer Society Cancer Action Network (ACS CAN) in New York are calling on Governor Kathy Hochul to take urgent action to reduce the state’s lung cancer burden by signing legislation that will eliminate cost-sharing for lung cancer screening and follow-up tests. As the advocates’ calls reach a fever pitch, new data, published in JAMA, has emerged to indicate that lung cancer screening uptake is low with only 1 in 5 eligible adults in the U.S. getting screened for lung cancer.

Earlier today, a new bill was introduced in the New York City Council to improve New Yorkers’ access to cancer screening. Int. #1369-2025 will require all private employers with a staff of five or more to grant employees paid time off—up to five hours annually—for preventative medical care, including doctor-recommend screening, ensuring that fear of wage or job loss does not serve as a barrier to workers’ ability to prevent, detect and ultimately survive cancer.

“With just days left in the legislative session, the New York State Assembly must not leave Albany without reforming the state’s inadequate Temporary Disability Insurance (TDI) program--for the second year in a row."